Sandra P D'Angelo, MD
@sandrapdangelo
Followers
2K
Following
3K
Media
6
Statuses
525
Sarcoma & Merkel cell carcinoma Medical oncologist l Immunotherapy expert l Memorial Sloan Kettering Cancer Center l Tweets are my own
New York, NY
Joined May 2015
Wonderful colleague and collaborator!.
#ScienceSaturday. ❓Can engineered T-cell therapies offer new hope for patients with advanced soft tissue sarcomas?. ➡️ In this pilot study, D’Angelo (@sandrapdangelo) of @MSKCancerCenter et al., with contributions from Dr. Mihaela Druta (@MihaelaDruta) of @MoffittNews,
0
2
8
RT @MSKCancerCenter: Join sarcoma medical oncologist @sandrapdangelo TODAY for her session on "Development of Afami-Cel–Engineered Cell The….
0
3
0
RT @ctosociety: CTOS President @SilviaStacchia is inviting everyone to join the Annual Meeting in Boca Raton and celebrate 30th Anniversary….
0
21
0
Had a great time visiting Regis today and speaking with students about recent advances in cancer research and my work in sarcoma treatment. Grateful for the warm welcome and thoughtful questions—future scientists in the making! #CancerResearch @RegisHighSchool @MSKCancerCenter.
Dr. Sandra D’Angelo P’28, a Memorial Sloan Kettering medical oncologist, visited Regis today to speak with students about recent breakthroughs in cancer research. She also spoke about her role in groundbreaking studies to better treat those who have been diagnosed with sarcoma.
2
4
40
RT @oncodaily: 🎙️Dr. Sandra D’Angelo highlights the IGNYTE-ESO trial, where Lete-cel shows a 42% response rate in synovial sarcoma and MRCL….
0
7
0
RT @OncLive: Hear @sandrapdangelo of @MSKCancerCenter and @NamBuiMD of @StanfordCancer discuss developing targeted therapies that effective….
0
1
0
RT @breelynwilkyMD: Join us in Boulder, CO April 3, 2025 for inaugural Rocky Mountain #Sarcoma Symposium! incredible speakers @sandrapdang….
0
3
0
RT @AdamJSchoenfeld: Thrilled to share our article this Thanksgiving Eve! 🍂 With expansion of HLA-restricted therapies, we show HLA genotyp….
0
8
0
RT @bvantine1: It's ok at #CTOS2024 to drag me to your poster to pitch your science for Clinical Cancer Research, it the most inspiring thi….
0
4
0
RT @ctosociety: The final countdown until #CTOS2024 meeting!.4 days full of great science and networking with #sarcoma experts - researche….
0
22
0
RT @CCR_AACR: Phase 2 Study (JAVELIN Merkel 200): Biomarker analyses - avelumab for metastatic Merkel cell carcinoma. .
0
3
0
RT @jitcancer: Here’s a closer look at #JITC article: A multicenter, randomized, non-comparative, phase II study of nivolumab +/- ipilimuma….
0
3
0
RT @KlebanoffLab: Overview in @NatureBiotech discussing the recent landmark approval of the 1st #TCR gene therapy approval. Appreciate the….
0
19
0
RT @jitcancer: New #JITC article: A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with me….
0
4
0
RT @OncNewsCentral: Afami-cel is now the first engineered cell therapy approved for a solid tumor, offering new hope for metastatic #synovi….
0
1
0
RT @oncodaily: FDA Grants Accelerated Approval to Afamitresgene Autoleucel (TECELRA) for Treating Advanced Synovial Sarcoma .@sandrapdangel….
0
3
0
RT @OncNewsCentral: Afami-cel is now the first engineered cell therapy approved for a solid tumor, offering new hope for metastatic #synovi….
0
1
0
RT @MSK_DeptOfMed: The FDA just approved the immunotherapy afami-cel for adults with #synovial sarcoma based on a trial led by @MSKCancerCe….
0
7
0
RT @TargetedOnc: 🚨The FDA approved afami-cel in advanced synovial sarcoma! Want to dive deeper into SPEARHEAD-1 trial findings?. 🔒Sign up t….
0
2
0
Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the foundation for future efforts in solid tumors.
8
28
94